Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 158,672 shares at $18.45 ($2.9M) on 2023-04-13, disclosed to the SEC on 2023-04-13.
Open-market sale of $2.9M VKTX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.45 | 79,336 | $1.5M | 50.0% |
| 2 | $18.45 | 79,336 | $1.5M | 50.0% |
| Total | $18.45 avg | 158,672 | $2.9M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |